Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on July 07th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on June 4th. The trade occurred in the Representative’s “UBS BROKERAGE ACCOUNT” account.
Representative Maria Elvira Salazar also recently made the following trade(s):
- Purchased $15,001 – $50,000 in shares of Voyager Technologies (NYSE:VOYG) on 6/15/2026.
- Purchased $15,001 – $50,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/4/2026.
- Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/4/2026.
- Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/3/2026.
- Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/2/2026.
- Purchased $15,001 – $50,000 in shares of Salesforce (NYSE:CRM) on 6/2/2026.
- Sold $15,001 – $50,000 in shares of Biogen (NASDAQ:BIIB) on 6/2/2026.
- Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 5/29/2026.
- Purchased $15,001 – $50,000 in shares of International Business Machines (NYSE:IBM) on 5/21/2026.
- Purchased $15,001 – $50,000 in shares of Datadog (NASDAQ:DDOG) on 5/19/2026.
UnitedHealth Group Stock Down 0.6%
UNH stock opened at $425.61 on Thursday. The business’s fifty day moving average price is $397.02 and its two-hundred day moving average price is $337.55. The stock has a market capitalization of $386.52 billion, a price-to-earnings ratio of 32.15, a PEG ratio of 1.72 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $430.77. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a $2.32 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is currently 70.09%.
UnitedHealth Group News Summary
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UnitedHealth said an external audit found nearly 97% of diagnoses made through its HouseCalls home-health unit were supported by patient medical records, which could help ease concerns about improper billing practices. UnitedHealth says most home-health diagnoses were supported in 2025
- Positive Sentiment: The company is set to report quarterly earnings on Thursday, and the setup has investors focused on whether recent execution can continue to support the stock after a strong first-half rebound. UnitedHealth Group (UNH) to Post Quarterly Earnings on Thursday
- Positive Sentiment: UnitedHealth is planning a roughly $1.5 billion AI investment in 2026 to expand automation and digital tools, which could improve efficiency and potentially support growth beyond cost savings. UNH’s $1.5B AI Push: Can It Deliver More Than Cost Savings?
- Neutral Sentiment: Some market commentary is cautioning investors not to buy UNH too quickly, arguing that while healthcare is growing, UnitedHealth may not be the best sector pick right now. Don’t Buy UnitedHealth Group (UNH) Stock Before Reading This
- Negative Sentiment: UnitedHealth, CVS, and Cigna are suing over new state laws aimed at pharmacy businesses, highlighting continued regulatory and legal risk for the managed-care and pharmacy-benefit segment. Health Insurance Giants Are Fighting Efforts to Break Them Up
Insider Buying and Selling at UnitedHealth Group
In other news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.28% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On UnitedHealth Group
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Sarver Vrooman Wealth Advisors bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $25,000. Beacon Financial Strategies CORP bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC grew its stake in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $27,000. Finally, Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group during the fourth quarter valued at about $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research firms have recently weighed in on UNH. Wells Fargo & Company upped their target price on UnitedHealth Group from $370.00 to $397.00 and gave the company an “overweight” rating in a research report on Wednesday, April 22nd. TD Cowen reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Monday, June 22nd. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $453.00 to $468.00 and gave the company an “overweight” rating in a research report on Tuesday, June 30th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $395.00 to $440.00 and gave the company a “buy” rating in a research note on Monday, June 1st. Finally, Oppenheimer upped their price objective on UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $414.75.
View Our Latest Stock Analysis on UnitedHealth Group
About Representative Salazar
Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.
Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.
Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Scotiabank Sees a New Growth Story for Cloudflare
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
